Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01647581 · ClinicalTrials.gov registry record · NA
Risk of Post-polypectomy Bleeding With Prophylactic Hemoclipping
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 11,182
- Enrollment target
NCT01647581: Completed NA study, sponsored by VA Office of Research and Development.
NCT01647581 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 11,182 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01647581, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 11,182 participants
- Enrollment target
Study Summary
A randomized trial aimed at determining whether or not hemoclips are effective in preventing post-polypectomy bleeds on polyps that are 10mm in size or greater.
Interventions
- DEVICE Hemoclip Placement
- DEVICE NO hemoclip placement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11,182 participants |
| Start Date | 2011-09-01 |
| Est. Completion | 2018-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01647581
The ClinicalTrials.gov registry entry for NCT01647581 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11,182 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hemoclip Placement is the first listed.
NCT01647581 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01647581 about?
NCT01647581 is a clinical study titled "Risk of Post-polypectomy Bleeding With Prophylactic Hemoclipping". A randomized trial aimed at determining whether or not hemoclips are effective in preventing post-polypectomy bleeds on polyps that are 10mm in size or greater.
What is the current status of trial NCT01647581?
This trial is currently completed. It is a NA study. The enrollment target is 11,182 participants. The study started on 2011-09-01. Estimated completion is 2018-11-01.
What interventions are being tested in trial NCT01647581?
The interventions under investigation include: Hemoclip Placement (DEVICE), NO hemoclip placement (DEVICE).
Who is sponsoring clinical trial NCT01647581?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.